Targeting STING in experimental peritoneal damage: a novel approach in peritoneal dialysis therapy
Preprint
Abstract
Peritoneal dialysis (PD) is a widely used kidney replacement therapy for end-stage kidney disease (ESKD) patients. However, long-term exposure to PD fluids (PDF) can lead to peritoneal membrane (PM) damage, causing ultrafiltration failure and thus PD discontinuation. Investigating the molecular mechanisms underlying this damage is crucial for identifying new therapeutic targets to mitigate peritoneal deterioration in PD patients. Therefore, in this work we study the role of STING in peritoneal inflammation and fibrosis. To this aim, we performed different preclinical mouse models of peritoneal inflammation, fibrosis, and adhesions. In a chlorhexidine gluconate (CHX)-induced inflammation model, we found changes in the peritoneal transcriptomic profile, and cytosolic DNA-sensing signaling was one of the most enriched KEGG pathways. STING, as a conspicuous member of this pathway, was upregulated in CHX-and PDF-exposed mice, and in peritoneal biopsies from PD patients. STING genetic deficiency diminished peritoneal inflammation, by downregulating inflammatory gene expression, preventing NF-κB pathway activation, and decreasing cell infiltration, in early (10 days) and advanced (30 days) stages of the CHX model. STING absence also decreased PM thickness and fibrosis in the advanced CHX model, reduced adhesion scores in a post-surgical intra-abdominal adhesion model, and decreased inflammation in an S. epidermidis -induced peritonitis model. Furthermore, pharmacological inhibition of STING with C-176 decreased inflammation and macrophage-mediated mesothelial-to-mesenchymal transition in cultured mesothelial cells, and reduced CHX-induced PM thickness and inflammation in mice. Altogether, these findings highlight STING as a key mediator of peritoneal damage and suggest it may be a novel therapeutic target for preventing PD-associated peritoneal deterioration.Keywords
This publication has 91 references indexed in Scilit:
- STING1 deficiency ameliorates immune‐mediated crescentic glomerulonephritis in miceThe Journal of Pathology, 2023
- Lipotoxicity-induced mtDNA release promotes diabetic cardiomyopathy by activating the cGAS-STING pathway in obesity-related diabetesCell Biology and Toxicology, 2022
- Cytoplasmic DNA: sources, sensing, and role in aging and diseaseCell, 2021
- Double knockout of Akt2 and AMPK accentuates high fat diet-induced cardiac anomalies through a cGAS-STING-mediated mechanismBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stressBiomedicine & Pharmacotherapy, 2020
- TBK1 and IKKε Act Redundantly to Mediate STING-Induced NF-κB Responses in Myeloid CellsCell Reports, 2020
- The Cyclopeptide Astin C Specifically Inhibits the Innate Immune CDN Sensor STINGCell Reports, 2018
- Mesothelial‐to‐mesenchymal transition in the pathogenesis of post‐surgical peritoneal adhesionsThe Journal of Pathology, 2016
- Pattern Recognition Receptors and InflammationCell, 2010
- Trex1 Prevents Cell-Intrinsic Initiation of AutoimmunityCell, 2008